BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7667398)

  • 21. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Findlay JM; Macdonald RL; Weir BK
    Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intra-arterial papaverine on the chronic period of cerebral arterial vasospasm in rats.
    Kazan S
    Acta Neurol Scand; 1998 Nov; 98(5):354-9. PubMed ID: 9858107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium blocking agents for treatment of cerebral vasospasm.
    Peck S
    J Neurosurg Nurs; 1983 Jun; 15(3):123-7. PubMed ID: 6553074
    [No Abstract]   [Full Text] [Related]  

  • 25. Lazaroids and deferoxamine attenuate the intracellular effects of oxyhaemoglobin in vascular smooth muscle.
    Vollrath B; Chan P; Findlay M; Cook D
    Cardiovasc Res; 1995 Oct; 30(4):619-26. PubMed ID: 8575010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm.
    Gioia AE; White RP; Bakhtian B; Robertson JT
    J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral arterial reactivity and spasm after subarachnoid haemorrhage.
    Du Boulay G; Symon L; Shah S; Dorsch N; Ackerman R
    Proc R Soc Med; 1972 Jan; 65(1):80-2. PubMed ID: 4622641
    [No Abstract]   [Full Text] [Related]  

  • 28. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
    Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
    Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of inflammation in experimental cerebral vasospasm.
    Peterson JW; Kwun BD; Hackett JD; Zervas NT
    J Neurosurg; 1990 May; 72(5):767-74. PubMed ID: 2182792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral vasospasm after subarachnoid hemorrhage.
    Chyatte D; Sundt TM
    Mayo Clin Proc; 1984 Jul; 59(7):498-505. PubMed ID: 6376963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of cerebral vasospasm: with special references to the response of fresh human cerebral arteries to red blood cell hemolysate and the changes in the responses of cerebral arteries to vasoconstrictor substances after subarachnoid hemorrhage].
    Handa Y
    Nihon Geka Hokan; 1987 Mar; 56(2):124-37. PubMed ID: 3115214
    [No Abstract]   [Full Text] [Related]  

  • 32. Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid hemorrhage with nimodipine. Report on 3 cases.
    Böker DK; Solymosi L; Wassmann H
    Neurochirurgia (Stuttg); 1985 May; 28 Suppl 1():118-20. PubMed ID: 4010867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasospasm due to massive subarachnoid haemorrhage--a rat model.
    Ram Z; Sahar A; Hadani M
    Acta Neurochir (Wien); 1991; 110(3-4):181-4. PubMed ID: 1927612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm.
    Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ion channels and calcium signaling in cerebral arteries following subarachnoid hemorrhage.
    Wellman GC
    Neurol Res; 2006 Oct; 28(7):690-702. PubMed ID: 17164032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs.
    Nozaki K; Uemura Y; Okamoto S; Kikuchi H; Mizuno N
    J Neurosurg; 1989 Oct; 71(4):558-64. PubMed ID: 2795174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nimodipine and chronic vasospasm in monkeys: Part 2. Pharmacological studies of vessels in spasm.
    Krueger C; Weir B; Nosko M; Cook D; Norris S
    Neurosurgery; 1985 Feb; 16(2):137-40. PubMed ID: 3974823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diltiazem protects against functional changes in chronic cerebrovasospasm in monkeys.
    Bevan RD; Bevan JA; Frazee JG
    Stroke; 1988 Jan; 19(1):73-9. PubMed ID: 3122376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of vasospasm due to subarachnoid hemorrhage with calcium entry blockers.
    Przuntek H; von Baumgarten F; Mertens HG
    Eur Neurol; 1986; 25 Suppl 1():86-92. PubMed ID: 3530777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.